Retrieve available abstracts of 14 articles: HTML format
Single Articles
August 2025
CIOFFI M, Moirano G, Isaevska E, Fiano V, et al Postnatal determinants of testicular germ cell tumor by histological subtypes:
The EPSAM1 and EPSAM2 studies.
Int J Cancer. 2025 Aug 13. doi: 10.1002/ijc.70083. PubMedAbstract available
June 2025
AJAJ R, Gershon AS, Lau C, Gupta S, et al Pulmonary toxicity in children, adolescents, and young adults with testicular
germ cell tumors: A population-based retrospective matched cohort study.
Int J Cancer. 2025 Jun 24. doi: 10.1002/ijc.70017. PubMedAbstract available
PYRGIDIS N, Apfelbeck M, Kidess M, Weinhold P, et al The perioperative outcomes of retroperitoneal lymph node dissection in Germany
for patients with testicular cancer: Results from the GRAND study.
Int J Cancer. 2025 Jun 4. doi: 10.1002/ijc.35486. PubMedAbstract available
April 2025
STAERK MG, Kaderly Rasmussen EL, Hannibal CG, Hertzum-Larsen R, et al Histologically verified penile lichen sclerosus-Incidence in Denmark over
26 years and long-term risk of penile and non-penile cancer.
Int J Cancer. 2025 Apr 18. doi: 10.1002/ijc.35454. PubMedAbstract available
November 2024
WATLING CZ, Kelly RK, Watts EL, Graubard BI, et al Total testosterone, sex hormone-binding globulin, and free testosterone
concentrations and risk of primary liver cancer: A prospective analysis of
200,000 men and 180,000 postmenopausal women.
Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35244. PubMedAbstract available
April 2024
CAI X, Liang C, Zhang M, Dong Z, et al Mitochondrial DNA copy number and cancer risks: A comprehensive Mendelian
randomization analysis.
Int J Cancer. 2024;154:1504-1513. PubMedAbstract available
SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al Antibodies against high-risk human papillomavirus proteins as markers for
noncervical HPV-related cancers in a Black South African population, according to
HIV status.
Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919. PubMedAbstract available
March 2024
DOHERTY N, Cardwell C, Murchie P, Hill C, et al Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men
with benign prostatic hyperplasia: A population-based cohort study.
Int J Cancer. 2024 Mar 30. doi: 10.1002/ijc.34937. PubMedAbstract available
February 2024
HAAVISTO A, Lampic C, Wettergren L, Lahteenmaki PM, et al Reproductive late effects and testosterone replacement therapy in male childhood
cancer survivors: A population-based study (the Fex-Can study).
Int J Cancer. 2024 Feb 22. doi: 10.1002/ijc.34890. PubMedAbstract available
December 2023
BREEKVELDT ECH, Ykema BLM, Bisseling TM, Moons LMG, et al Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated
with platinum-based chemotherapy.
Int J Cancer. 2023 Dec 27. doi: 10.1002/ijc.34810. PubMedAbstract available
October 2023
HUGHES NF, Cromie KJ, Feltbower RG, McCabe MG, et al Delivered relative dose intensity in adolescent and young adult germ cell tumours
in England: Assessment of data quality and consistency from clinical trials
compared to national cancer registration data.
Int J Cancer. 2023 Oct 20. doi: 10.1002/ijc.34762. PubMedAbstract available
August 2023
ALONSO-CRISOSTOMO L, Trendell J, Ferraresso M, Bailey S, et al Testicular germ cell tumour cells release microRNA-containing extracellular
vesicles that induce phenotypic and genotypic changes in cells of the tumour
microenvironment.
Int J Cancer. 2023 Aug 26. doi: 10.1002/ijc.34697. PubMedAbstract available
June 2023
THORSEN L, Courneya KS, Steene-Johannessen J, Gran JM, et al Association of physical activity with overall mortality among long-term
testicular cancer survivors: A longitudinal study.
Int J Cancer. 2023 Jun 19. doi: 10.1002/ijc.34625. PubMedAbstract available
May 2023
HEMMINKI K, Forsti A, Liska V, Kanerva A, et al Long-term survival trends in solid cancers in the Nordic countries marking timing
of improvements.
Int J Cancer. 2023;152:1837-1846. PubMedAbstract available